Grothusen Christina, Friedrich Christine, Ulbricht Ulysses, Meinert Jette, Attmann Tim, Huenges Katharina, Borzikowsky Christoph, Haneya Assad, Schoettler Jan, Cremer Jochen
Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
Medizinische Klinik I, St. Johannes Hospital Dortmund, 44137 Dortmund, Germany.
Rev Cardiovasc Med. 2022 Jun 24;23(7):237. doi: 10.31083/j.rcm2307237. eCollection 2022 Jul.
Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains associated with a high rate of mortality and disabling morbidity. Coronary artery bypass grafting (CABG) is seldom considered in this setting due to the fear of peri-operative complications. Here, we analysed the outcome of CS patients undergoing CABG within 48 hours after diagnosed with AMI.
A single-center, retrospective data analysis was performed in 220 AMI patients with CS that underwent CABG within 48 hours between 01/2001 and 01/2018.
141 patients were diagnosed with ST-elevation myocardial infarction (STEMI), 79 with non-STEMI (NSTEMI). Median age was 67 (60; 72) for STEMI, and 68 (60.8; 75.0) years for NSTEMI patients ( = 0.190). 52.5% of STEMI patients and 39.2% of NSTEMI patients had suffered from cardiac arrest (CA) pre-operatively ( = 0.049). Coronary 3-vessel disease was present in most patients (78.0% STEMI vs 83.5% NSTEMI; = 0.381). Percutaneous coronary interventions (PCI) were performed in 32.6% STEMI and 27.8% NSTEMI patients ( = 0.543) prior to surgery. Time from diagnosis to surgery was shorter in STEMI patients (3.92 (2.67; 5.98) vs 7.50 (4.78; 16.74) hours; 0.001). A complete revascularization was achieved in 82.3% of STEMI and 73.4% of NSTEMI cases ( = 0.116). Post-operative low cardiac output occurred in 14.2% of STEMI vs 8.9% of NSTEMI patients ( = 0.289). The rate of cerebrovascular injury-including hypoxic brain damage was 12.1% for STEMI and 10.1% among NSTEMI patients. ( = 0.825). 30-day mortality was 32.6% after STEMI vs 31.6% in NSTEMI cases ( = 0.285).
In contrast to the discouraging data concerning the role of PCI in AMI patients with CS and complex coronary artery disease, CABG may represent a treatment option worth considering.
急性心肌梗死(AMI)合并心源性休克(CS)的死亡率和致残率仍然很高。由于担心围手术期并发症,冠状动脉旁路移植术(CABG)在这种情况下很少被考虑。在此,我们分析了在诊断为AMI后48小时内接受CABG的CS患者的结局。
对2001年1月至2018年1月期间在48小时内接受CABG的220例AMI合并CS患者进行了单中心回顾性数据分析。
141例患者被诊断为ST段抬高型心肌梗死(STEMI),79例为非ST段抬高型心肌梗死(NSTEMI)。STEMI患者的中位年龄为67岁(60;72),NSTEMI患者为68岁(60.8;75.0)(P = 0.190)。52.5%的STEMI患者和39.2%的NSTEMI患者术前发生过心脏骤停(CA)(P = 0.049)。大多数患者存在冠状动脉三支病变(STEMI患者中为78.0%,NSTEMI患者中为83.5%;P = 0.381)。32.6%的STEMI患者和27.8%的NSTEMI患者在手术前接受了经皮冠状动脉介入治疗(PCI)(P = 0.543)。STEMI患者从诊断到手术的时间较短(3.92(2.67;5.98)小时对7.50(4.78;16.74)小时;P < 0.001)。82.3%的STEMI病例和73.4%的NSTEMI病例实现了完全血运重建(P = 0.116)。STEMI患者术后低心排血量发生率为14.2%,NSTEMI患者为8.9%(P = 0.289)。包括缺氧性脑损伤在内的脑血管损伤发生率在STEMI患者中为12.1%,在NSTEMI患者中为10.1%(P = 0.825)。STEMI患者30天死亡率为32.6%,NSTEMI患者为31.6%(P = 0.285)。
与PCI在AMI合并CS及复杂冠状动脉疾病患者中作用的令人沮丧的数据相反,CABG可能是一个值得考虑的治疗选择。